Heart of the Data

DEFER 5-Year Results: Redefining PCI Decisions

13 min · 29 de ago de 2025
Portada del episodio DEFER 5-Year Results: Redefining PCI Decisions

Descripción

In this episode, we unpack the landmark DEFER 5-year trial, which asked a simple but game-changing question: should every coronary lesion be stented? The study showed that deferring PCI in lesions with an FFR > 0.75 was safe and effective, with excellent 5-year outcomes. We’ll explore how these results reshaped interventional cardiology and why the DEFER trial still guides decision-making today.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Heart of the Data!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

10 episodios

episode CALIPSO Trial: OCT-Guided PCI in Calcified Coronary Lesions artwork

CALIPSO Trial: OCT-Guided PCI in Calcified Coronary Lesions

In this episode, we delve into the CALIPSO (Calcified Lesion Intervention Planning Steered by OCT) trial, a pivotal study evaluating the efficacy of optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) compared to traditional angiography-guided PCI in patients with moderate to severe calcified coronary lesions. Conducted across 12 centers in France, the trial demonstrated that OCT-guided PCI, utilizing a predefined lesion preparation algorithm, resulted in significantly larger minimal stent areas and improved stent expansion without increasing procedural risks. We explore the trial's design, key findings, and discuss the potential implications for interventional cardiology practice.

6 de jun de 202516 min